We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
+7.37%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$9.69B
AUM Growth
+$805M
Cap. Flow
+$420M
Cap. Flow %
4.33%
Top 10 Hldgs %
28.55%
Holding
286
New
47
Increased
108
Reduced
76
Closed
36

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$93.3M
2
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$64.9M
3
AMZN icon
Amazon
AMZN
+$58.3M
4
SYK icon
Stryker
SYK
+$56.3M
5
PRAH
PRA Health Sciences, Inc.
PRAH
+$49.9M

Top Sells

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$77M
2
AMGN icon
Amgen
AMGN
+$72.2M
3
AET
Aetna Inc
AET
+$65.7M
4
CELG
Celgene Corp
CELG
+$54.3M
5
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$52.8M

Sector Composition

Rank Sector Weight
1 Financials 21.51%
2 Healthcare 20.26%
3 Technology 19.08%
4 Communication Services 10.55%
5 Industrials 6.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ATVI
76
DELISTED
Activision Blizzard
ATVI
$40.8M 0.42%
644,552
+975
+0.2% +$61.6K
LOXO
77
DELISTED
Loxo Oncology, Inc
LOXO
$40.6M 0.42%
481,800
+21,800
+5% +$1.82M
BAH icon
78
Booz Allen Hamilton
BAH
$8.7B
$40.3M 0.42%
1,057,790
+100,072
+10% +$3.79M
AON icon
79
Aon
AON
$77.3B
$40.3M 0.42%
300,800
-252,402
-46% -$35.9M
SPLK
80
DELISTED
Splunk Inc
SPLK
$40M 0.41%
482,510
-326,323
-40% -$23.9M
BIIB icon
81
Biogen
BIIB
$29.9B
$39.3M 0.41%
123,413
+75,913
+160% +$24.4M
LVNTA
82
DELISTED
Liberty Interactive Corporation Series A Liberty Ventures
LVNTA
$38.6M 0.4%
711,177
-71,355
-9% -$4.06M
AABA
83
DELISTED
Altaba Inc
AABA
$36.4M 0.38%
520,520
+86,958
+20% +$6.05M
FCX icon
84
Freeport-McMoran
FCX
$90B
$36.2M 0.37%
1,906,905
-111,154
-6% -$1.68M
NTES icon
85
NetEase
NTES
$76.5B
$35.4M 0.37%
513,025
-11,250
-2% -$703K
ANSS
86
DELISTED
Ansys
ANSS
$35M 0.36%
237,346
+107,637
+83% +$15.2M
CI icon
87
Cigna
CI
$76.6B
$34.5M 0.36%
170,000
– –
OXFD
88
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$34.4M 0.36%
2,465,022
+100,000
+4% +$1.46M
ICLR icon
89
Icon
ICLR
$12.8B
$33.8M 0.35%
301,330
-715
-0.2% -$82.4K
MIME
90
DELISTED
Mimecast Limited
MIME
$33.4M 0.34%
1,164,793
+190,589
+20% +$5.68M
OLED icon
91
Universal Display
OLED
$3.71B
$33.2M 0.34%
192,651
-172,491
-47% -$27.5M
ACRS icon
92
Aclaris Therapeutics
ACRS
$730M
$33M 0.34%
1,339,931
-6,118
-0.5% -$149K
ILMN icon
93
Illumina
ILMN
$29.4B
$32.8M 0.34%
154,470
– –
DVAX
94
DELISTED
Dynavax Technologies
DVAX
$32.7M 0.34%
1,750,000
– –
LH icon
95
Labcorp
LH
$24.3B
$32.6M 0.34%
238,004
+145,932
+158% +$19.3M
VRTX icon
96
Vertex Pharmaceuticals
VRTX
$121B
$32.6M 0.34%
217,500
+101,000
+87% +$15M
PEN icon
97
Penumbra
PEN
$12.5B
$32.5M 0.34%
345,385
+11,755
+4% +$1.17M
LEXEA
98
DELISTED
Liberty Expedia Holdings, Inc. Class A Common Stock
LEXEA
$32.3M 0.33%
729,453
-1,757
-0.2% -$84.4K
EGHT icon
99
8x8 Inc
EGHT
$247M
$31.9M 0.33%
2,263,884
+760,508
+51% +$10.5M
CGNX icon
100
Cognex
CGNX
$10.3B
$31.4M 0.32%
514,072
-164,684
-24% -$10.5M
2 3
4
5 6

Similar funds

ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return
FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Polar Capital's Q4 2017 Portfolio in Review

As of Q4 2017, Polar Capital held 286 positions worth $9.69B, up 9.1% from $8.89B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Polar Capital deployed $420M of net new capital in Q4 2017, opening 47 new positions and adding to 108 existing holdings. Its largest new stake was Alnylam Pharmaceuticals: 516,232 shares worth $65.6M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Aetna Inc, an estimated $65.7M trimmed.

  • Polar Capital's largest Q4 2017 buy was Alnylam Pharmaceuticals: 516,232 shares worth $65.6M.
  • Polar Capital added most to Microsoft in Q4 2017, an estimated $93.3M increase.
  • Polar Capital's biggest Q4 2017 reduction was Aetna Inc, cutting an estimated $65.7M.
  • Polar Capital fully exited PepsiCo in Q4 2017, selling an estimated $77M.
  • Polar Capital's ten largest holdings make up 29% of its $9.69B portfolio in Q4 2017.
  • Polar Capital opened 47 new positions and closed 36 in Q4 2017.
  • Polar Capital's portfolio value rose 9.1% quarter-over-quarter to $9.69B.

Based on Polar Capital's 13F filing for Q4 2017, filed 14 Feb 2018.